Study S002117

Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05767255
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 66
Start: 2022-12-01
Primary completion: 2023-08-30
Lead sponsor: Hospital Universitario San Ignacio
Conditions: Diabetes Mellitus, Type 2 Treated With Insulin
Interventions: DRUG:insulin degludec + liraglutide; DRUG:Insulin Glargine - Insulin Aspart
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

To compare the percentage of hypoglycemia [4 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0007026	Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial. Gómez-Medina AM, Diabetologia	2025	Randomized trial	PMID 40760249 DOI	cites ClinicalTrials.gov:NCT05767255; registry reference DERIVED:40760249